Legal Representation
Attorney
Robert E. Rosenthal
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 15, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 15, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 13, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 11, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 11, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jan 11, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jul 14, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 12, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 12, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 12, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 12, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 17, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 17, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 28, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 15, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Oct 15, 2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 15, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Oct 15, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Oct 15, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 8, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 29, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 6, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 036
Management of investment funds, namely, investing in entities in the fields of biotechnology and bio-engineering; Equity capital investment in the fields of biotechnology and bio-engineering
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
CAPITAL DNA
Classification
International Classes
036
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CAPITAL"